IRIS
ESPOSITO, Emanuela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.204
EU - Europa 19.701
AS - Asia 11.719
SA - Sud America 3.558
Continente sconosciuto - Info sul continente non disponibili 895
AF - Africa 320
OC - Oceania 25
Totale 57.422
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.354
RU - Federazione Russa 10.167
SG - Singapore 4.980
CN - Cina 3.204
BR - Brasile 2.985
IE - Irlanda 2.199
IT - Italia 2.000
SE - Svezia 1.818
HK - Hong Kong 1.177
DE - Germania 692
VN - Vietnam 638
FR - Francia 520
GB - Regno Unito 502
PL - Polonia 425
UA - Ucraina 423
CA - Canada 360
FI - Finlandia 348
IN - India 332
BD - Bangladesh 307
AR - Argentina 188
MX - Messico 158
TR - Turchia 138
NL - Olanda 131
AT - Austria 113
JP - Giappone 111
ID - Indonesia 108
ZA - Sudafrica 103
EC - Ecuador 100
IQ - Iraq 98
BE - Belgio 88
PK - Pakistan 83
VE - Venezuela 77
CO - Colombia 76
ES - Italia 72
UZ - Uzbekistan 72
MA - Marocco 67
CR - Costa Rica 57
MY - Malesia 49
CL - Cile 43
IL - Israele 43
AE - Emirati Arabi Uniti 39
IR - Iran 37
SV - El Salvador 36
JM - Giamaica 35
GT - Guatemala 33
JO - Giordania 32
PY - Paraguay 32
SA - Arabia Saudita 32
HN - Honduras 31
PH - Filippine 31
TT - Trinidad e Tobago 31
LT - Lituania 30
TN - Tunisia 28
CZ - Repubblica Ceca 26
NP - Nepal 26
NI - Nicaragua 25
PE - Perù 23
KE - Kenya 22
AZ - Azerbaigian 20
DZ - Algeria 20
AU - Australia 19
KG - Kirghizistan 19
UY - Uruguay 19
EG - Egitto 18
OM - Oman 17
TH - Thailandia 17
CW - ???statistics.table.value.countryCode.CW??? 16
DO - Repubblica Dominicana 16
EE - Estonia 16
PS - Palestinian Territory 16
DK - Danimarca 14
PR - Porto Rico 14
TW - Taiwan 14
HU - Ungheria 13
BO - Bolivia 12
GP - Guadalupe 12
PA - Panama 12
CI - Costa d'Avorio 11
KR - Corea 11
KZ - Kazakistan 11
RS - Serbia 11
CH - Svizzera 10
LB - Libano 10
SC - Seychelles 10
NO - Norvegia 9
PT - Portogallo 9
AL - Albania 8
AO - Angola 8
BB - Barbados 8
BG - Bulgaria 8
BY - Bielorussia 8
GE - Georgia 8
RO - Romania 8
BS - Bahamas 7
ET - Etiopia 6
LA - Repubblica Popolare Democratica del Laos 6
QA - Qatar 6
EU - Europa 5
GR - Grecia 5
LV - Lettonia 5
Totale 56.447
Salva come PNG Salva come JPEG
Città #
Ashburn 3.447
Moscow 2.966
Singapore 2.467
Dublin 2.199
Dallas 1.708
Chandler 1.615
San Jose 1.253
Nyköping 1.215
Hong Kong 1.167
Beijing 943
Jacksonville 835
Council Bluffs 668
The Dalles 529
Messina 445
Los Angeles 437
Princeton 407
Warsaw 399
New York 353
Dearborn 348
Lauterbourg 333
Medford 314
Boardman 278
Des Moines 267
Cambridge 251
São Paulo 240
Munich 238
Santa Clara 234
Ann Arbor 232
Buffalo 201
Ho Chi Minh City 192
Tianjin 153
Rome 137
Guangzhou 135
Hanoi 133
Lancaster 129
Redondo Beach 121
Houston 117
Milan 114
Orem 112
Rio de Janeiro 105
Shenyang 101
Jinan 100
Phoenix 96
Montreal 93
Tokyo 93
North Bergen 91
Wilmington 89
Chicago 86
Atlanta 85
Brussels 82
Catania 79
Vienna 79
Frankfurt am Main 74
Brooklyn 73
Nanjing 73
Belo Horizonte 67
Chennai 66
Denver 64
Pune 64
San Mateo 64
San Francisco 63
Ottawa 62
Shanghai 62
Tashkent 62
Woodbridge 62
London 58
Naples 56
Cologne 53
Turku 53
Brasília 52
Johannesburg 52
Columbus 51
Mexico City 51
Seattle 51
Hyderabad 50
Shenzhen 50
Baghdad 49
Dong Ket 48
Hebei 48
Jakarta 48
Zhengzhou 47
Ningbo 46
Curitiba 45
Toronto 45
Palermo 44
Amsterdam 43
Stockholm 43
Haikou 42
Boston 40
Düsseldorf 39
Guayaquil 38
Philadelphia 38
Campinas 37
Manchester 36
San José 36
Poplar 35
Porto Alegre 35
Washington 35
Helsinki 34
Nuremberg 34
Totale 30.929
Salva come PNG Salva come JPEG
Nome #
Dimethyl fumarate reduces inflammatory responses in experimental colitis 301
Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man 299
Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor-alpha 266
Glycogen synthase kinase-3 beta inhibition reduces secondary damage in experimental spinal cord trauma. 265
2-Pentadecyl-2-oxazoline, the oxazoline of PEA, modulates carrageenan-induced acute inflammation 262
Erratum to: Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice. 256
A Systematic Review and Meta-Analysis of the Association between the FV H1299R Variant and the Risk of Recurrent Pregnancy Loss 250
Role of peroxisome proliferator-activated receptor-alpha in acute pancreatitis induced by cerulein 245
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of inflammatory bowel disease 244
Erratum to: Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain 241
The anti-inflammatory effects of palmitoylethanolamide (PEA) on endotoxin-induced uveitis in rats 240
PPAR-α Modulates the Anti-Inflammatory Effect of Melatonin in the Secondary Events of Spinal Cord Injury 237
B-Cell Depletion with CD20 Antibodies as New Approach in the Treatment of Inflammatory and Immunological Events Associated with Spinal Cord Injury 232
A new co-micronized composite containing palmitoylethanolamide and polydatin shows superior oral efficacy compared to their association in a rat paw model of carrageenan-induced inflammation 230
Absence of endogenous Interleukin-10 enhances secondary inflammatory process after spinal cord compression injury in mice. 228
Influence of coagulase-negative staphylococci as potential probiotics on Dry Eye 227
3,5-Dicaffeoyl-4-malonylquinic acid reduced oxidative stress and inflammation in a experimental model of inflammatory bowel disease 225
MK801 attenuates secondary injury in a mouse experimental compression model of spinal cord trauma 224
Celenterati Cnidari come modello per lo studio di tossicità da metalli pesanti. 223
B Cell depletion with CD20 antibodies as new approach in the treatment of inflammatory and immunological events associated with spinal cord 220
Effects of Physical Exercise and Motor Activity on Oxidative Stress and Inflammation in Post Mastectomy Pain Syndrome 218
Recent Emerging Immunological Treatments for Primary Brain Tumors: Focus on Chemokine-Targeting Immunotherapies 218
Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome 218
BAY-117082-driven NLRP3 inflammasome inhibition resolves nitro-glycerine (NTG) neuronal damage in in vivo model of migraine 214
Melatonin regulates matrix metalloproteinases after traumatic experimental spinal cord injury. 213
Protein Hydrolysates from Anchovy (Engraulis encrasicolus) Waste: In Vitro and In Vivo Biological Activities 213
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of acute and chronic inflammation 212
Correction to: Potential eye drop based on a calix[4]arene nanoassembly for curcumin delivery: Enhanced drug solubility, stability, and anti-inflammatory effect (Molecular Pharmaceutics (2017) 14:5 (1610-1622) DOI: 10.1021/acs.molpharmaceut.6b01066) 210
Antioxidant and anti-inflammatory effect of nrf2 inducer dimethyl fumarate in neurodegenerative diseases 210
Beneficial effect of tempol, a membrane-permeable radical scavenger, on inflammation and osteoarthritis in in vitro models 210
Co-Ultra PEALut Enhances Endogenous Repair Response Following Moderate Traumatic Brain Injury 207
Beneficial effect of KYP-2047, a propyl-oligopeptidase inhibitor, on oral squamous cell carcinoma 206
Co-ultramicronized palmitoylethanolamide/luteolin promotes neuronal regeneration after spinal cord injury 205
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of inflammatory bowel disease 205
Anti-inflammatory and Antioxidant Effects of Flavonoid-Rich Fraction of Bergamot Juice (BJe) in a Mouse Model of Intestinal Ischemia/Reperfusion Injury 202
B Cell-Targeted Therapy with Anti-CD20 Monoclonal Antibody Reduced Secondary Tissue Damage and Enhanced Behavioural Recovery Following Experimental Spinal Cord Injury in Mice 202
A novel protective formulation of Palmitoylethanolamide in experimental model of contrast agent induced nephropathy 201
Administration of palmitoylethanolamide (PEA) protects the neurovascular unit and reduces secondary injury after traumatic brain injury in mice. 200
Effect of a Product Containing Xyloglucan and Pea Protein on a Murine Model of Atopic Dermatitis 198
A role for nitric oxide-mediated peroxynitrite formation in a model of endotoxin-induced shock 196
Dimethyl fumarate attenuates neuroinflammation and neurobehavioral deficits induced by experimental traumatic brain injury 195
Dimethyl fumarate alleviates the nitroglycerin (NTG)-induced migraine in mice 195
Effect of ultra-micronized-palmitoylethanolamide and acetyl-l-carnitine on experimental model of inflammatory pain 195
Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury 194
Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism 194
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury 191
Efficacy of Xyloglucan against Escherichia coli Extraintestinal Urinary Tract Infection: An in vivo Study 190
Palmitoylethanolamide Reduces Early Renal Dysfunction and Injury Caused by Experimental Ischemia and Reperfusion in Mice. 188
Role of melatonin supplementation in neurodegenerative disorders. 187
Carbon dots as promising tools for cancer diagnosis and therapy 187
Effects of palmitoylethanolamide and silymarin combination treatment in an animal model of kidney ischemia and reperfusion 186
Evaluation of a Product Containing Xyloglucan and Pea Protein on Skin Barrier Permeability 186
A hydrogen sulfide-releasing cyclooxygenase inhibitor markedly accelerates recovery from experimental spinal cord injury. 185
A Combination of Xyloglucan, Pea Protein and Chia Seed Ameliorates Intestinal Barrier Integrity and Mucosa Functionality in a Rat Model of Constipation-Predominant Irritable Bowel Syndrome 184
H1299R Variant in Factor V and Recurrent Pregnancy Loss: A Systematic Review and Meta-Analysis Protocol 183
Adverse Reactions to Evolocumab: Analysis of Real-World Data from EudraVigilance 182
Activation of sphingosine-1-phosphate receptor subtype 1 in the central nervous system contributes to morphine-induced hyperalgesia and antinociceptive tolerance in rodents 182
Efficacy of Palmitoylethanolamide and Luteolin Association on Post-Covid Olfactory Dysfunction: A Systematic Review and Meta-Analysis of Clinical Studies 181
Absence of peroxisome proliferators activated receptors alpha (PPAR-) enhanced the multiple organ failure induced by zymosan. 181
Adenosine A2A receptor selective stimulation reduces mitogen activated protein kinases in spinal cord injury: activation of jnk is reduced in oligodendrocytes 181
Ethyl-piruvate reduces the developments of zymosine-induced generalized inflammatory in mice 180
Evaluation of the nutraceutical Palmitoylethanolamide in reducing intraocular pressure (IOP) in patients with glaucoma or ocular hypertension: a systematic review and meta-analysis 178
Absence of TLR4 reduces neurovascular unit and secondary inflammatory process after traumatic brain injury in mice 178
Anti-inflammatory and neuroprotective effects of co-ultraPEALut in a mouse model of vascular dementia 176
A New Approach for the Treatment of Recurrent Vulvovaginal Candidiasis with a Combination of Pea Protein, Grape Seed Extract, and Lactic Acid Assessed In Vivo 175
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-alpha MODULATES THE ANTI-INFLAMMATORY EFFECT OF GLUCOCORTICOIDS IN A MODEL OF INFLAMMATORY BOWEL DISEASE IN MICE. 175
The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2 174
Adenosine A3 receptor as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury 174
Effects of Physical Exercise and Motor Activity on Depression and Anxiety in Post-Mastectomy Pain Syndrome 173
Aspetti tossicologici di estratto crudo da Pelagia noctiluca (Cnidaria: Scyphozoa). 173
TAK1 inhibitor enhances the therapeutic treatment for glioblastoma 173
Efficacy of an oral suspension containing xyloglucan and pea proteins on a murine model of gastroesophageal reflux disease 172
Therapeutic potential of flavonoids in the treatment of chronic venous insufficiency 172
Dimethyl Fumarate (DMF) Alleviated Post-Operative (PO) Pain through the N-Methyl-d-Aspartate (NMDA) Receptors 171
Adenosine A2a receptor agonists reduce the apoptosis in an experimental model of spinal cord trauma (Biological Regulators and Homeostatical Agents (73)) 171
A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways. 170
N-palmitoylethanolamine administration ameliorates the clinical manifestation and progression of experimental autoimmune encephalomyelitis in rodents 170
Effects of a co-micronized composite containing palmitoylethanolamide and polydatin in an experimental model of benign prostatic hyperplasia 170
The Association of Palmitoylethanolamide with Luteolin Decreases Autophagy in Spinal Cord Injury 170
Adenosine Targeting as a New Strategy to Decrease Glioblastoma Aggressiveness 168
The neuroprotective effects of co-ultraPEALut in a mouse model of spinal cord injury 167
Glycogen synthase kinase 3 beta inhibition reduces the development of nonseptic shock induced by zymosan in mice 165
Fumaric Acid Esters Attenuate Secondary Degeneration and Promote Functional Recovery Following Experimental Spinal Cord Injury 165
Autophagy and Liver Diseases 164
Effect of co-ultramicronized palmitoylethanolamide and luteolin association on neurogenesis in a mouse model of spinal cord injury 164
The protective role of prolyl oligopeptidase (pop) inhibition in acute lung injury induced by intestinal ischemia-reperfusion 164
Efficacy of a Product Containing Xyloglucan and Pea Protein on Intestinal Barrier Function in a Partial Restraint Stress Animal Model 164
Glucocorticoid-induced tumor necrosis factor receptor-related (GITR)-Fc fusion protein inhibits GITR triggering and protects from the inflammatory response after spinal cord injury 163
Role of Dkk-3 in the neoplastic progression of meningiomas. Could it represent a new therapeutic target? 163
BENEFICIAL EFFECTS OF ETHYL PYRUVATE IN A MOUSE MODEL OF SPINAL CORD INJURY. 162
Anti-inflammatory effect of simvastatin in an experimental model of spinal cord trauma: involvement of PPAR-α. 161
PDE 7 inhibitors: new potential drugs for the therapy of spinal cord injury. 159
Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain 159
Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives 158
Ultramicronized palmitoylethanolamide (PEA-um(®)) in the treatment of idiopathic pulmonary fibrosis 158
Au, Pd and maghemite nanofunctionalized hydroxyapatite scaffolds for bone regeneration 157
Melatonin reduces stress-activated/mitogen-activated protein kinases in spinal cord injury 156
Inhibition of Poly(ADP-Ribose) Polymerase Activity Modulates Autophagy Induced by Experimental Spinal Cord Trauma 156
Potential Therapeutic Effects of PPAR Ligands in Glioblastoma 156
ABCB1-Mediated Colchicine Transport and Its Implications in Familial Mediterranean Fever: A Systematic Review 154
Totale 19.498
Salva come PNG Salva come JPEG
Categoria #
all - tutte 202.361
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 202.361
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.077 0 0 0 92 117 36 181 91 75 132 470 883
2022/20236.430 533 524 288 528 465 644 95 356 2.705 46 178 68
2023/20241.836 128 271 108 156 157 404 81 101 23 99 35 273
2024/20258.657 164 89 250 404 410 248 278 1.590 2.137 505 1.046 1.536
2025/202626.685 1.342 1.594 2.020 1.962 2.130 5.445 3.168 3.073 3.241 1.340 577 793
2026/20275.712 732 1.239 1.555 2.186 0 0 0 0 0 0 0 0
Totale 57.422